Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Janssen Pharmaceutica
🇧🇪
Belgium
Country
🇧🇪
Belgium
Ownership
-
Established
1953-01-01
Employees
10K
Market Cap
-
Website
http://www.janssenpharmaceutica.be/
Clinical Trials
Related News
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
Completed
Conditions
Psoriasis
Plaque
Interventions
Other: No Intervention
Subscribe
First Posted Date
2014-10-24
Last Posted Date
2017-03-27
Lead Sponsor
Janssen Pharmaceutica
Target Recruit Count
1131
Registration Number
NCT02274363
Subscribe
An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain
Phase 4
Completed
Conditions
Osteoarthritis
Low Back Pain
Interventions
Drug: Fentanyl
Subscribe
First Posted Date
2013-02-21
Last Posted Date
2013-07-15
Lead Sponsor
Janssen Pharmaceutica
Target Recruit Count
237
Registration Number
NCT01795898
Subscribe
An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis
Phase 4
Completed
Conditions
Vulva; Candidiasis
Interventions
Drug: Miconazole plus Hydrocortisone
Subscribe
First Posted Date
2013-01-16
Last Posted Date
2013-03-25
Lead Sponsor
Janssen Pharmaceutica
Target Recruit Count
115
Registration Number
NCT01769339
Subscribe
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Completed
Conditions
Pneumonia, Bacterial
Nosocomial Infection
Intraabdominal Infections
Urinary Tract Infection
Interventions
Drug: No intervention
Subscribe
First Posted Date
2013-01-08
Last Posted Date
2013-08-09
Lead Sponsor
Janssen Pharmaceutica
Target Recruit Count
170
Registration Number
NCT01763008
Subscribe
A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia
Withdrawn
Conditions
Chronic Lymphocytic Leukemia
Interventions
Drug: No intervention
Subscribe
First Posted Date
2012-12-03
Last Posted Date
2015-12-02
Lead Sponsor
Janssen Pharmaceutica
Registration Number
NCT01739491
Subscribe
An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis
Phase 4
Completed
Conditions
Osteoarthritis
Interventions
Drug: Tramadol/Paracetamol (APAP)
Drug: Non-Tramadol/APAP
Subscribe
First Posted Date
2012-11-19
Last Posted Date
2013-02-12
Lead Sponsor
Janssen Pharmaceutica
Target Recruit Count
473
Registration Number
NCT01728246
Locations
🇵ðŸ‡
Janssen Philippines, Paranaque City, Metro Manila, Philippines
Subscribe
A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Withdrawn
Conditions
Human Immunodeficiency Virus-Type 1
Interventions
Drug: No intervention
Subscribe
First Posted Date
2012-11-14
Last Posted Date
2015-12-02
Lead Sponsor
Janssen Pharmaceutica
Registration Number
NCT01726348
Subscribe
A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain
Withdrawn
Conditions
Moderate to Severe Acute Non-Cancer Pain
Interventions
Drug: No intervention
Subscribe
First Posted Date
2012-11-01
Last Posted Date
2015-09-28
Lead Sponsor
Janssen Pharmaceutica
Registration Number
NCT01719601
Subscribe
A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain
Withdrawn
Conditions
Moderate to Severe Chronic Non-cancer Pain
Interventions
Drug: No intervention
Subscribe
First Posted Date
2012-11-01
Last Posted Date
2015-12-02
Lead Sponsor
Janssen Pharmaceutica
Registration Number
NCT01719588
Subscribe
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Withdrawn
Conditions
Prostate Neoplasms
Interventions
Drug: Abiraterone acetate
Drug: Prednisone
Subscribe
First Posted Date
2012-09-25
Last Posted Date
2015-12-02
Lead Sponsor
Janssen Pharmaceutica
Registration Number
NCT01692483
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy